Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Atlas Energy Solutions | AESI | 28. jui 2024 | 19.93 | +0.81 |
Atlas Lithium | ATLX | 28. jui 2024 | 10.38 | 0.00 |
Atlas Pref D | ATCO-D | 28. jui 2024 | 24.89 | -0.24 |
Atlas Pref H | ATCO-H | 28. jui 2024 | 24.64 | -1.20 |
AtlasClear Holdings | ATCH | 28. jui 2024 | 1.04 | +8.29 |
Atlassian A | TEAM | 28. jui 2024 | 176.88 | +2.25 |
Atmos Energy | ATO | 28. jui 2024 | 116.65 | +0.09 |
Atmus Filtration Technologies | ATMU | 28. jui 2024 | 28.78 | +0.28 |
ATN International | ATNI | 28. jui 2024 | 22.80 | +0.89 |
Atomera | ATOM | 28. jui 2024 | 3.81 | -5.22 |
Atossa Therapeutics | ATOS | 28. jui 2024 | 1.19 | +4.39 |
Atour Lifestyle ADR | ATAT | 28. jui 2024 | 18.35 | +1.83 |
ATRenew A ADR | RERE | 28. jui 2024 | 2.37 | +7.73 |
AtriCure | ATRC | 28. jui 2024 | 22.77 | -2.23 |
Atrion | ATRI | 28. jui 2024 | 452.43 | -0.16 |
ATS Corporation | ATS | 28. jui 2024 | 32.31 | -0.40 |
aTyr Pharma | ATYR | 28. jui 2024 | 1.56 | 0.00 |
aTyr Pharma | LIFE | 28. jui 2024 | 1.90 | 0.00 |
Auburn National Bank | AUBN | 28. jui 2024 | 18.29 | +1.22 |
Auddia | AUUD | 28. jui 2024 | 0.97 | +0.25 |
AudioCodes | AUDC | 28. jui 2024 | 10.38 | +1.17 |
AudioEye | AEYE | 28. jui 2024 | 17.61 | +2.50 |
Augmedix | AUGX | 28. jui 2024 | 0.88 | +3.54 |
Ault Alliance | AULT | 28. jui 2024 | 0.29 | +2.55 |
Ault Disruptive Technologies SPAC | ADRT | 28. jui 2024 | 16.00 | -4.53 |
Auna S.A.A | AUNA | 28. jui 2024 | 8.00 | 0.00 |
Aura Biosciences | AURA | 28. jui 2024 | 7.56 | +3.85 |
Aura FAT Projects Acquisition A | AFAR | 28. jui 2024 | 11.30 | 0.00 |
Aurinia Pharmaceuticals | AUPH | 28. jui 2024 | 5.71 | +1.60 |
Aurora Cannabis | ACB | 28. jui 2024 | 4.62 | -2.33 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.